Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates
- 10 October 2010
- journal article
- Published by Elsevier BV in Virology
- Vol. 406 (1), 65-79
- https://doi.org/10.1016/j.virol.2010.07.011
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primatesVirology, 2010
- Evasion of Interferon Responses by Ebola and Marburg VirusesJournal of Interferon & Cytokine Research, 2009
- The Regulation of Type I Interferon Production by ParamyxovirusesJournal of Interferon & Cytokine Research, 2009
- Paramyxovirus Disruption of Interferon Signal Transduction: STATus ReportJournal of Interferon & Cytokine Research, 2009
- Rotavirus Antagonizes Cellular Antiviral Responses by Inhibiting the Nuclear Accumulation of STAT1, STAT2, and NF-κBJournal of Virology, 2009
- Influenza B Virus NS1-Truncated Mutants: Live-Attenuated Vaccine ApproachJournal of Virology, 2008
- Human Parainfluenza Virus Type 1 C Proteins Are Nonessential Proteins That Inhibit the Host Interferon and Apoptotic Responses and Are Required for Efficient Replication in Nonhuman PrimatesJournal of Virology, 2008
- Human Parainfluenza Virus Type 2 V Protein Inhibits Genome Replication by Binding to the L Protein: Possible Role in Promoting Viral FitnessJournal of Virology, 2008
- Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3′ genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primatesVaccine, 2007
- Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear AccumulationJournal of Virology, 2006